https://www.selleckchem.com/
72 (CC1 95% CI = 0.51-1.03, P = 0.07) for PPI users and 0.95 (CC2 95% CI = 0.74-1.22, P = 0.69) for H2 antagonist users, when compared to non-users. Between the patients using acid suppressants, there was no difference between PPI and H2 antagonist users in the risk of developing dementia (CC3 aHR = 0.82, 95% CI = 0.58-1.17, P = 0.28). In conclusion, no association was observed between the use of acid suppressants and the risk of developing dementia in any of the three CCs. Further, randomized controlled trials are warranted to confirm this relationship.Gen
Curtir
Comentario
Compartilhar
